Mostrando 8 resultados de: 8
Filtros aplicados
Área temáticas
Salud y seguridad personal(7)
Enfermedades(4)
Ginecología, obstetricia, pediatría, geriatría(4)
Farmacología y terapéutica(2)
Problemas sociales y servicios a grupos(2)
Área de conocimiento
Ginecología(5)
Fisiología(2)
Enfermedad cardiovascular(1)
Estudios de género(1)
Medicamento(1)
Origen
scopus(8)
EMAS position statement: Non-hormonal management of menopausal vasomotor symptoms
ArticleAbstract: Aim: To review non-hormonal therapy options for menopausal vasomotor symptoms. The current EMAS posiPalabras claves:Behavioral therapies, Gabapentin, MENOPAUSE, Non-hormonal management, Selective serotonin-reuptake inhibitors, vasomotor symptomsAutores:Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A.Fuentes:scopusEMAS position statement: The ten point guide to the integral management of menopausal health
ArticleAbstract: With increased longevity and more women becoming centenarians, management of the menopause and postrPalabras claves:Hot Flushes, menopausal hormone therapy, MENOPAUSE, OSTEOPOROSIS, Postreproductive health, screeningAutores:Birkhauser M., Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Llaneza P., Neves-E-Castro M., Palacios S., Rees M., Samsioe G., Sánchez-Borrego R., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopusEMAS recommendations for conditions in the workplace for menopausal women
ArticleAbstract: Women form a large part of many workforces throughout Europe. Many will be working throughout theirPalabras claves:MENOPAUSE, Women, workplaceAutores:Ceausu I., Depypere H., Faustino R. Pérez-López, Griffiths A., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., van der Schouw Y.T.Fuentes:scopusMaintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS)
ArticleAbstract: This position statement from the European Menopause and Andropause Society (EMAS) provides a care paPalabras claves:genitourinary syndrome of menopause, hormone therapy, Hot Flushes, MENOPAUSE, OSTEOPOROSIS, WomenAutores:Armeni E., Ceausu I., Depypere H., Faustino R. Pérez-López, Lambrinoudaki I., Mueck A., Rees M., Schouw Y.T.V.D., Senturk L.M., Simoncini T., Stevenson J.C., Stute P.Fuentes:scopusManagement of urinary incontinence in postmenopausal women: An EMAS clinical guide
ArticleAbstract: Introduction: The prevalence of urinary incontinence and of other lower urinary tract symptoms increPalabras claves:aging, estrogens, MENOPAUSE, Midurethral slings, Urinary incontinenceAutores:Bitzer J., Cano A., Caretto M., Ceausu I., Durmusoglu F., Erkkola R., Giannini A., Goulis D.G., Hirschberg A.L., Kiesel L., Lambrinoudaki I., Lopes P., Peter A. Chedraui, Pines A., Rees M., Russo E., Simoncini T., van Trotsenburg M.Fuentes:scopusMenopause and diabetes: EMAS clinical guide
ArticleAbstract: Introduction: Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independentlyPalabras claves:menopausal hormone therapy, MENOPAUSE, Type 2 Diabetes mellitusAutores:Anagnostis P., Cano A., Goulis D.G., Jaremek J.D., Lambrinoudaki I., Lopes P., Meczekalski B., Mishra G.D., Mueck A., Paschou S.A., Peter A. Chedraui, Rees M., Rogowicz-Frontczak A., Senturk L.M., Simoncini T., Slopien R., Stevenson J.C., Stute P., Tuomikoski P., Wender-Ozegowska E., Zozulinska-Ziolkiewicz D.Fuentes:scopusMetabolic Syndrome and Excessive Body Weight in Peri-and Postmenopausal Women
Book PartAbstract: Metabolic syndrome (MetS) has been associated with the endocrine, metabolic, and immunological functPalabras claves:Cardiovascular Risk, Hormone replacement therapy (HRT), MENOPAUSE, Metabolic syndrome (MetS), obesityAutores:Genazzani A.R., Giannini A., Montt-Guevara M.M., Palla G., Peter A. Chedraui, Shortrede J.E., Simoncini T.Fuentes:scopusWhy sex matters: The biological mechanisms of cardiovascular disease
ArticleAbstract: Cardiovascular disease (CVD) is the leading determinant of mortality and morbidity in women. HoweverPalabras claves:Cardiovascular Risk, gender, MENOPAUSE, Sex, steroid hormonesAutores:Faustino R. Pérez-López, Peter A. Chedraui, Simoncini T., Vassalle C.Fuentes:scopus